Skip to content

CYTOSORBENTS CORPORATION: 10-K filed 2012-03-30

What CYTOSORBENTS CORPORATION reported in its annual report filed 2012-03-30 (fiscal FY 2011): 32 published measures, 97 facts as tagged in accession 0001144204-12-018905.

This filing

Form
10-K (annual report)
Filed
2012-03-30
Fiscal period
fiscal FY 2011
Accession
0001144204-12-018905 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CYTOSORBENTS CORPORATION filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2011-12-312,122,542USD
At 2010-12-311,811,926USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2011-12-311,804,199USD
At 2010-12-312,296,507USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2011-12-31318,343USD
At 2010-12-31-484,581USD
At 2009-12-311,267,715USD
At 2008-12-312,359,481USD
At 2007-12-31-104,296USD
At 2006-12-312,363,005USD
At 2005-12-31-9,760,207USD
At 2004-12-31-6,967,944USD
At 2003-12-31-3,907,307USD
At 2002-12-31-4,374,976USD
At 2001-12-312,329,208USD
At 2000-12-315,340,631USD
At 1999-12-31100,548USD
At 1998-12-311,580,034USD
At 1997-12-31877,475USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2011-12-311,186,653USD
At 2010-12-311,055,669USD
At 2009-12-311,595,628USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2011-01-01 to 2011-12-31-5,481,648USD365
1997-01-22 to 2011-12-31-84,146,919USD5457
2010-01-01 to 2010-12-31-2,908,865USD365
2009-01-01 to 2009-12-31-2,736,715USD365
2008-01-01 to 2008-12-31-3,017,890USD366
2007-01-01 to 2007-12-31-3,350,754USD365
2006-01-01 to 2006-12-31-7,671,580USD365
2005-01-01 to 2005-12-31-3,665,596USD365
2004-01-01 to 2004-12-31-1,096,683USD366
2003-01-01 to 2003-12-31-6,009,283USD365
2002-01-01 to 2002-12-31-11,871,668USD365
2001-01-01 to 2001-12-31-15,392,618USD365
2000-01-01 to 2000-12-31-10,753,871USD366
1999-01-01 to 1999-12-31-3,066,388USD365
1998-01-01 to 1998-12-31-1,867,348USD365
1997-01-22 to 1997-12-31-5,256,012USD344

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-01-01 to 2011-12-31-3,828,527USD365
1997-01-22 to 2011-12-31-62,577,409USD5457
2010-01-01 to 2010-12-31-2,477,258USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2011-01-01 to 2011-12-3134,672USD365
1997-01-22 to 2011-12-312,400,960USD5457
2010-01-01 to 2010-12-31139,356USD365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2011-01-01 to 2011-12-3136,078USD365
1997-01-22 to 2011-12-3136,078USD5457

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-01-01 to 2011-12-314,012,001USD365
1997-01-22 to 2011-12-3168,244,257USD5457
2010-01-01 to 2010-12-312,102,748USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-01-01 to 2011-12-31-52,490USD365
1997-01-22 to 2011-12-31-4,480,195USD5457
2010-01-01 to 2010-12-31-165,449USD365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
1997-01-22 to 2011-12-31-547,318USD5457

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2011-12-31155,067USD
At 2010-12-31144,146USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-12-31-4,436,767USD365
1997-01-22 to 2011-12-31-77,833,900USD5457
2010-01-01 to 2010-12-31-2,824,019USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-12-311,697,481USD
At 2010-12-311,400,205USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-12-311,527,949USD
At 2010-12-311,219,119USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2011-12-31675,160USD
At 2010-12-31817,701USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2011-12-3136,078USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2011-01-01 to 2011-12-314,461,085USD365
1997-01-22 to 2011-12-3177,858,218USD5457
2010-01-01 to 2010-12-312,824,019USD365

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2011-12-31431,022USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2011-01-01 to 2011-12-3124,318USD365
1997-01-22 to 2011-12-3124,318USD5457

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2011-01-01 to 2011-12-312,888,245USD365
1997-01-22 to 2011-12-3150,899,338USD5457
2010-01-01 to 2010-12-311,757,370USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2011-12-31177,626,058shares
At 2010-12-31122,838,411shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2011-12-3192,696,747USD
At 2010-12-3183,375,544USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2011-12-31269,994USD
At 2010-12-31267,575USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2011-12-3143,728USD
At 2010-12-31344,536USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2011-01-01 to 2011-12-31-8,568,692USD365
1997-01-22 to 2011-12-31-92,557,542USD5457
2010-01-01 to 2010-12-31-5,086,329USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2011-01-01 to 2011-12-311,230,189USD365
1997-01-22 to 2011-12-3125,056,473USD5457
2010-01-01 to 2010-12-31759,387USD365

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
1997-01-22 to 2011-12-31183,556USD5457

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2011-01-01 to 2011-12-31-1,044,881USD365
1997-01-22 to 2011-12-31-6,860,337USD5457
2010-01-01 to 2010-12-31-84,846USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
1997-01-22 to 2011-12-31400,490USD5457

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-12-3136,078USD365
1997-01-22 to 2011-12-3136,078USD5457

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-12-31431,022USD365
1997-01-22 to 2011-12-31431,022USD5457

Inspect the source

Entity
CYTOSORBENTS CORPORATION / CIK 0001175151
Captured
2026-09-20T07:44:44.168Z
SEC response SHA-256
8bb195ec858f16302b2a8454a5ffe3eff6c1e6cd0312136a64a7a2f621b86836

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001175151.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))